2Park WJ, Cho YJ, Kim YG, et al. Active and passive protective effect of CFC-101 (Pseudomonas vaccine) in mice. J Appl Pharmacol,1994,2:326-330.
3Lee NG, Bhn BY, Jung SB, et al. Human anti-Pseudomonas aeruginosa outer membrane proteins IgG cross-prective against infection with heterologous Immunotype strains of P. Aeruginosa. FEMS Immunol And Med Microbiol,1999,25:339-347.
4Lee NG, Jung SB, Ahn BY, et al. Immunization of burn-patients with a pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy. Vaccine,2000,18: 1952-1961.
1Doig P, Trust TJ. Identification of surface-exposed outer membrane antigens of Helicobacter pylori. Infect Immun, 1994, 62:4526～4533.
2Wirth HP, Beins MH, Yang M, Tham KT, Blaser MJ. Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infect Immun,1998,66:4856～4866.
3Guy B, Hessler C, Fourage S, Rokbi B, Millet MJ.Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice. Vaccine,1999,17:1130～1135.
4Ferrero RL, Thiberge JM, Kansan I, Wuscher N,Huerre M, Labigne A. Immunization with helicobacter heat shock protein A and urease subunit B affords total protection against H. felis infection in mice. Gut, 1995, 37(Suppl):A203.
5Kleanthous H, Lee CK, Monath TP. Vaccine development against infection with Helicobacter pylori. Br Med Bull, 1998,54:229～241.
6Kleanthous H, Myers GA, Georgakopoulos KM,Tibbitts TJ, Ingrassia JW, Gray HL, Ding R,Zhang ZZ, Lei W, Nichols R, Lee CK, Ermak TH,Monath TP. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun,1998,66:2879～2886.
7Dubois A, Lee CK, Fiala N, Kleanthous H, Mehlman PT, Monath T. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun,1998,66:4340～4346.
8Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthesy-Theulaz I, Losonsky G, Nichols R, Simon J,Stolte M, Ackerman S, Monath TP, Blum AL.Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori infected adults. Gastroenterology, 1999,116:804～812.
1Larbig M, Mansouri E, Freihorst J, et al. Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers [ J]. Vaccine, 2001, 19(17/18/19) :2291-2297.
2Baumann U, Mansouri E, yon Specht BU. Recombinant OprF-Oprl as a vaccine against Pseudomonas aeruginosa infections [J]. Vaccine, 2004, 22 ( 7 ) : 840- 847.
3Mansouri E, Blome-Eberwein S, Gabelsberger J, et al. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients. FEMS Immunol Med Microbiol, 2003, 37 (2/3) : 161-166.
4Baumann U, Gocke K, Gewecke B, et al. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudornonas aeruginosa: a clinical phase Ⅰ/Ⅱ study [J]. Respir Res, 2007, 8:57.
5Jang I J, Kim IS, Park W J, et al. Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine [ J ]. Vaccine, 1999, 17 (2) : 158-168.
6Kim DK, Kim JJ, Kim JH, et al. Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients [J]. Vaccine, 2000, 19(9/10) : 1274-1283.
7Lee NG, Jung SB, Ahn BY, et al. hnmunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy [J]. Vaccine, 2000, 18(18) : 1952-1961.
8Priebe GP, Brinig MM, Hatano K, et al. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine [ J ]. Infect Immun, 2002, 70 ( 3 ) : 1507-1517.
9Zaidi TS, Priebe GP, Pier GB. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection [ J ]. Infect hnmun, 2006, 74(2):975-983.
10Hertle R, Mrsny R, Fitzgerald DJ. Dual-function vaccine for Pseudomonas aeruginosa : characterization of chimeric exotoxin Apilin protein [J]. Infect Immun, 2001, 69( 11 ) :6962-6969.
